These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23500628)

  • 1. 3D-QSAR studies of azaoxoisoaporphine, oxoaporphine, and oxoisoaporphine derivatives as anti-AChE and anti-AD agents by the CoMFA method.
    Li YP; Weng X; Ning FX; Ou JB; Hou JQ; Luo HB; Li D; Huang ZS; Huang SL; Gu LQ
    J Mol Graph Model; 2013 Apr; 41():61-7. PubMed ID: 23500628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation and molecular modeling of oxoisoaporphine and oxoaporphine derivatives as new dual inhibitors of acetylcholinesterase/butyrylcholinesterase.
    Tang H; Wei YB; Zhang C; Ning FX; Qiao W; Huang SL; Ma L; Huang ZS; Gu LQ
    Eur J Med Chem; 2009 Jun; 44(6):2523-32. PubMed ID: 19243862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel oxoisoaporphine-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
    Tang H; Zhao HT; Zhong SM; Wang ZY; Chen ZF; Liang H
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2257-61. PubMed ID: 22341944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrids of oxoisoaporphine-tacrine congeners: novel acetylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation inhibitors.
    Tang H; Zhao LZ; Zhao HT; Huang SL; Zhong SM; Qin JK; Chen ZF; Huang ZS; Liang H
    Eur J Med Chem; 2011 Oct; 46(10):4970-9. PubMed ID: 21871694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
    Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
    Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
    He Y; Yao PF; Chen SB; Huang ZH; Huang SL; Tan JH; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2013 May; 63():299-312. PubMed ID: 23501115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA.
    Akula N; Lecanu L; Greeson J; Papadopoulos V
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6277-80. PubMed ID: 17049234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivatives of oxoisoaporphine alkaloids: a novel class of selective acetylcholinesterase inhibitors.
    Tang H; Ning FX; Wei YB; Huang SL; Huang ZS; Chan AS; Gu LQ
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3765-8. PubMed ID: 17451950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation of structurally diverse carbamates for acetylcholinesterase (AChE) inhibition using 3D-QSAR analysis.
    Roy KK; Dixit A; Saxena AK
    J Mol Graph Model; 2008 Sep; 27(2):197-208. PubMed ID: 18515163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntheses and characterization of novel oxoisoaporphine derivatives as dual inhibitors for cholinesterases and amyloid beta aggregation.
    Li YP; Ning FX; Yang MB; Li YC; Nie MH; Ou TM; Tan JH; Huang SL; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2011 May; 46(5):1572-81. PubMed ID: 21367493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multitarget-directed oxoisoaporphine derivatives: Anti-acetylcholinesterase, anti-β-amyloid aggregation and enhanced autophagy activity against Alzheimer's disease.
    Wei S; Chen W; Qin J; Huangli Y; Wang L; Shen Y; Tang H
    Bioorg Med Chem; 2016 Nov; 24(22):6031-6039. PubMed ID: 27720328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular docking and 3D-QSAR studies of 2-substituted 1-indanone derivatives as acetylcholinesterase inhibitors.
    Shen LL; Liu GX; Tang Y
    Acta Pharmacol Sin; 2007 Dec; 28(12):2053-63. PubMed ID: 18031622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Brunhofer G; Fallarero A; Karlsson D; Batista-Gonzalez A; Shinde P; Gopi Mohan C; Vuorela P
    Bioorg Med Chem; 2012 Nov; 20(22):6669-79. PubMed ID: 23062825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid β aggregation.
    Rouleau J; Iorga BI; Guillou C
    Eur J Med Chem; 2011 Jun; 46(6):2193-205. PubMed ID: 21435752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzophenone-based derivatives: a novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
    Belluti F; Bartolini M; Bottegoni G; Bisi A; Cavalli A; Andrisano V; Rampa A
    Eur J Med Chem; 2011 May; 46(5):1682-93. PubMed ID: 21397996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and evaluation of isaindigotone derivatives as dual inhibitors for acetylcholinesterase and amyloid beta aggregation.
    Yan JW; Li YP; Ye WJ; Chen SB; Hou JQ; Tan JH; Ou TM; Li D; Gu LQ; Huang ZS
    Bioorg Med Chem; 2012 Apr; 20(8):2527-34. PubMed ID: 22444876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-QSAR analysis of a new type of acetylcholinesterase inhibitors.
    Liu A; Guang H; Zhu L; Du G; Lee SM; Wang Y
    Sci China C Life Sci; 2007 Dec; 50(6):726-30. PubMed ID: 17914643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of berberine-thiophenyl hybrids as multi-functional agents: Inhibition of acetylcholinesterase, butyrylcholinesterase, and Aβ aggregation and antioxidant activity.
    Su T; Xie S; Wei H; Yan J; Huang L; Li X
    Bioorg Med Chem; 2013 Sep; 21(18):5830-40. PubMed ID: 23932451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
    Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A
    J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.